During the past decade, Knappschaftskrankenhaus Bottrop conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Knappschaftskrankenhaus Bottrop" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials sponsored, "Klinikum Arnsberg" with 1 trials sponsored, "Leipzig Heart Institute GmbH" with 1 trials sponsored and "Martin-Luther-Universität Halle-Wittenberg" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Knappschaftskrankenhaus Bottrop" #1 collaborator was "Boston Scientific Corporation" with 1 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Knappschaftskrankenhaus Bottrop" are "Crohn's Disease" (2 trials), "Atherosclerotic Disease" (1 trials), "Chronic Heart Failure" (1 trials), "Lymphoma" (1 trials) and "Metastatic Colorectal Cancer" (1 trials). Many other conditions were trialed in "Knappschaftskrankenhaus Bottrop" in a lesser frequency.

Most popular intervention types in "Knappschaftskrankenhaus Bottrop" are "Drug" (4 trials), "Biological" (1 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Mirikizumab" (2 trials), "5FU/LV, Oxaliplatin, Bevacizumab, Irinotecan" (1 trials), "CRT-D implantation" (1 trials), "CRT-P implantation" (1 trials) and "Oxaliplatin, 5FU/LV, Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Knappschaftskrankenhaus Bottrop" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Knappschaftskrankenhaus Bottrop". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Knappschaftskrankenhaus Bottrop, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Knappschaftskrankenhaus Bottrop, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".